04:29 PM EDT, 10/11/2024 (MT Newswires) -- Innocan Pharma ( INNPF ) on Friday said results were promising from a multi-year compassionate therapy using repeated liposomal-CBD (LPT-CBD) injections for pain relief in dogs with naturally-occurring osteoarthritis.

The company said therapy consistently demonstrated pain reduction and improved mobility, with effects lasting for several weeks after each injection as expected. These results further demonstrate that LPT-CBD can be a viable treatment option for managing chronic pain and enhancing the quality of life in animals.

In two ongoing cases, dogs suffering from osteoarthritis who were treated with LPT-CBD after failing to respond to non-steroidal anti-inflammatory drugs (NSAIDs) and oral CBD, showed noticeable pain relief, substantially improved mobility and increased, clearly noticeable well-being.

"We are thrilled with these findings, which highlight the long-lasting effects of repeated administration of LPT-CBD to treat chronic pain," said chief science officer Chezy Barenholz. "These results support the potential of LPT-CBD as a monthly treatment for chronic pain conditions, providing sustained relief."